newsroom

CMIA Logo

English / 中文

Newsroom - C&O Pharmaceutical Technology

Aug 1, 2011

Shionogi & Co., Ltd. to Acquire China-based C&O Pharmaceutical Technology (Holdings) Limited
May 13, 2011

C&O keeps its high gross profit margin at 62%, net profit attributable to shareholders amounted to HK$34 million in 3QFY2011
Feb 10, 2011

C&O achieves net profit of HK$29 million in 2QFY11
Dec 2, 2010

Sumitomo buys 29% of C&O for $96m
Dec 1, 2010

Sumitomo Corp acquires 29% strategic stake in C&O Pharmaceutical for S$96 million
Aug 24, 2010

High-margin drugs push C&O to record profit
Aug 23, 2010

C&O posts record year with FY2010 net profit up 44% to HK$156 million on revenue of HK$651 million
Aug 3, 2010

C&O inks RMB32 million deal to sell antiviral ingredients
May 11, 2010

C&O’s 3QFY10 net profit soars 40% to HK$41 million
Mar 25, 2010

C&O Receives PRC Government’s Eleventh Five-Year Plan Sponsorship Funding for its New Drug R&D Projects
Mar 9, 2010

Chinese drug firms see business booming
Feb 10, 2010

C&O’s 2QFY10 net profit jumps 18% to HK$30 million; Declares dividends of S$0.04
Nov 9, 2009

C&O’s 1QFY10 net profit jumps 52% to HK$26 million as sales of Exclusive and C&O Branded products surge

The information on this website is not an offer to sell or solicitation of an offer to buy an interest in any investment fund or for the provision of any investment management or advisory services. Any such offer or solicitation will be made only by means of delivery of a confidential private offering memorandum relating to a particular fund or investment management contract to qualified investors in those jurisdictions where permitted by law.